首页> 外国专利> METHOD FOR QUALITATIVE DETERMINATION OF THE DENTAL STATUS OF A PATIENT WITH SQUAMOUS CELL CARCINOMA OF THE ORAL MUCOSA IN INFLAMMATION OF THE MUCOUS MEMBRANE OF THE ALVEOLAR PROCESS OF THE JAW BY THE CONTENT OF THE BIOMARKERS IN THE ORAL FLUID

METHOD FOR QUALITATIVE DETERMINATION OF THE DENTAL STATUS OF A PATIENT WITH SQUAMOUS CELL CARCINOMA OF THE ORAL MUCOSA IN INFLAMMATION OF THE MUCOUS MEMBRANE OF THE ALVEOLAR PROCESS OF THE JAW BY THE CONTENT OF THE BIOMARKERS IN THE ORAL FLUID

机译:口腔液中生物标志物含量定量测定口腔黏膜鳞状细胞黏膜炎症时口腔黏膜鳞状细胞癌患者牙齿状况的方法

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, namely to laboratory diagnostics, and can be used for qualitative determination of a dental status of a patient with squamous cell carcinoma of oral mucosa with inflammation of the mucous membrane of the alveolar jaw. That is ensured by oral fluid intake in the patient, oral fluid centrifugation, oral fluid dilution with physiological saline, placing the patient's oral fluid ready for examination into a cell and performing a standard immunosorbent analysis on the basis of monoclonal antibodies with subsequent analysis of the test results. Matrix metalloproteinase 8 / matrix metalloproteinase 8 (MMP 8/MMP 8) and matrix metalloproteinase 9 / matrix metalloproteinase 9 (MMP 9/MMP 9) are used as biomarkers and their quantitative content in patient's oral fluid is determined, wherein the quantitative content of the biomarker in MMP 8/MMP 8 oral fluid of the clinical control group is taken to be 39.83–375.77 ng/ml, wherein the quantitative content of the biomarker in MMP 9/MMP oral fluid of 9th clinical control group is 59.8–304.62 ng/ml, wherein if oral content of MMP 8/MMP 8 is determined in amount of 527.17–1,242.67 ng/ml and MMP 9/MMP 9 in amount of 846.29–1,394.84 ng/ml, gingivitis of the alveolar mucous membrane is diagnosed process of jaw, wherein if oral content of MMP 8/MMP 8 is determined in amount of 1,498.15–56.51.1 ng/ml and MMP 9/MMP 9 in amount of 1,439.92–2,090.28 ng/ml, the parodontitis is diagnosed by a mucous membrane of the alveolar process of jaw.;EFFECT: invention increases accuracy and sensitivity of differential rapid diagnosis, high probability of detecting processes determining the dental status of the patient with squamous cell carcinoma of the oral mucosa in inflammation of the mucous membrane of the alveolar jaw in terms of content of biomarkers in the oral fluid, as well as considerable simplification of patient's preparation in certain time frames for sampling and storage of diagnostic material.;3 cl, 6 ex
机译:技术领域本发明涉及医学,即涉及实验室诊断,并且可以用于定性确定口腔粘膜鳞状细胞癌伴有牙槽颌粘膜炎症的患者的牙齿状况。这可以通过以下方式来确保:患者体内的口服液摄入,口服液离心,用生理盐水稀释口服液,将患者的口服液准备好检查进入细胞,并在单克隆抗体的基础上进行标准的免疫吸附剂分析,并随后对其进行分析。试验结果。基质金属蛋白酶8 /基质金属蛋白酶8(MMP 8 / MMP 8)和基质金属蛋白酶9 /基质金属蛋白酶9(MMP 9 / MMP 9)用作生物标志物,并确定其在患者口腔液中的定量含量,其中临床对照组的MMP 8 / MMP 8口服液中的生物标志物的取值为39.83–375.77 ng / ml,其中第9临床对照组的MMP 9 / MMP口服液中生物标志物的定量含量为59.8–304.62 ng / ml毫升,其中如果确定MMP 8 / MMP 8的口服含量为527.17–1,242.67 ng / ml和MMP 9 / MMP 9的含量为846.29–1,394.84 ng / ml,则可诊断为牙龈粘膜牙龈炎,其中,如果确定口服MMP 8 / MMP 8的含量为1,498.15-56.51.1 ng / ml,而测定MMP 9 / MMP 9的含量为1,439.92-2,090.28 ng / ml,则腮腺炎是通过口腔粘膜诊断的颌骨的牙槽突;效果:发明提高了颌骨的准确性和敏感性快速诊断,检测过程的高可能性,可根据口腔液中生物标志物的含量确定口腔粘膜鳞状细胞癌患者在牙槽颌粘膜炎症中的牙齿状况,并简化操作在一定时间范围内准备和准备诊断材料的准备工作; 3 cl,6 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号